{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:19Z","timestamp":1793724259970,"version":"4.6.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>In this study, molecular alterations in endometrial carcinoma (EC) recurrences were analyzed. We aimed to identify genes implicated in tumor progression and to evaluate whether histologic and molecular type shifting occurs in recurrences. Thus, we analyzed 50 samples corresponding to 24 primary ECs (15 low-grade endometrioid endometrial carcinomas [LG-EECs] and 9 high-grade endometrial carcinomas) and their corresponding 26 recurrences. These were studied by immunohistochemistry, next-generation sequencing, and <jats:italic toggle=\"yes\">MLH1<\/jats:italic> promoter methylation. We observed shared mutations in all primary tumors and their recurrences, indicating a clonal relationship between both lesions. Most morphologic and molecular changes associated with progression were found in LG-EEC. In this group, 6 patients (40%) presented additional mutations in the recurrence. These mutations more frequently affected genes of the PI3K\/AKT\/PTEN pathway, implicating this pathway not only in tumor initiation but also in progression. In addition, 2 patients (13%) in which the primary tumor belonged to the nonspecific molecular profile subtype, shifted to the mismatch repair deficient (MMRd) subtype after the acquisition of <jats:italic toggle=\"yes\">MLH1<\/jats:italic> promoter methylation in the recurrence lesions. In 3 patients (20%) with MMRd, there was a change from LG-EEC to G3-EEC. One <jats:italic toggle=\"yes\">TP53<\/jats:italic>-mutated LG-EEC transformed into an undifferentiated carcinoma in a mediastinal lymph node metastasis after losing the expression of SMARCA2 while preserving SMARCA4 and SMARCB1. Morphologic and molecular changes in EC recurrences, especially dedifferentiation and the acquisition of MMRd, should be considered for a correct diagnosis and treatment. MMRd should be tested in metastatic lesions, if available, in patients with primary tumors reported to be of a molecular subtype different from MMRd.<\/jats:p>","DOI":"10.1097\/pas.0000000000002308","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T13:13:48Z","timestamp":1726233228000},"page":"1580-1587","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors"],"prefix":"10.1097","volume":"48","author":[{"given":"Esther","family":"Moreno-Moreno","sequence":"first","affiliation":[{"name":"Department of Pathology"},{"name":"Department of Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Caniego-Casas","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Clinical Biostatistics Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-2965","authenticated-orcid":false,"given":"Irene","family":"Carretero-Barrio","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Department of Medical Oncology"},{"name":"Clinical Biostatistics Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Clinical Biostatistics Unit"},{"name":"Radiation Oncology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Muriel","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ram\u00f3n y Cajal University Hospital, Ram\u00f3n y Cajal Health Research Institute (IRYCIS)"},{"name":"Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute"},{"name":"Centre for Biomedical Research in Epidemiology and Public Health Networks (CIBERESP), Carlos III Health Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Dom\u00ednguez-Rull\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Autonomous University of Madrid (UAM), \u2018Alberto Sols\u2019 Biomedical Research Institute, Cancer Connection (UAM-CSIC)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mart\u00edn-Gromaz","sequence":"additional","affiliation":[{"name":"MD Anderson International Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Moreno-Bueno","sequence":"additional","affiliation":[{"name":"Clinical Biostatistics Unit"},{"name":"Faculty of Medicine"},{"name":"Nursery Department and Physiotherapy, Alcal\u00e1 University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mat\u00edas-Guiu","sequence":"additional","affiliation":[{"name":"Clinical Biostatistics Unit"},{"name":"Department of Pathology and Medical Oncology, Arnau de Vilanova University Hospital, IRBLLEIDA, University of Lleida"},{"name":"Department of Pathology, Bellvitge University Hospital, IDIBELL, University of Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6730-5066","authenticated-orcid":false,"given":"Jos\u00e9","family":"Palacios","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Department of Medical Oncology"},{"name":"Clinical Biostatistics Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5764-5182","authenticated-orcid":false,"given":"Bel\u00e9n","family":"P\u00e9rez-Mies","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Department of Medical Oncology"},{"name":"Clinical Biostatistics Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/cancers13050950","article-title":"ARID1A and CTNNB1\/\u03b2-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: implications for an improved surrogate molecular classification","volume":"13","author":"De Leo","year":"2021","journal-title":"Cancers"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cancers13112623","article-title":"New pathological and clinical insights in endometrial cancer in view of the updated ESGO\/ESTRO\/ESP guidelines","volume":"13","author":"Santoro","year":"2021","journal-title":"Cancers"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"526","DOI":"10.21873\/cgp.20338","article-title":"Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive analyses of clinicopathological, molecular, and prognostic characteristics with retrospective review of 237 endometrial carcinoma cases","volume":"19","author":"Kim","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.path.2022.02.006","article-title":"Endometrial cancer: an update on prognostic pathologic features and clinically relevant biomarkers","volume":"15","author":"Li","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/s41379-022-01066-y","article-title":"Genomic landscape of endometrial carcinomas of no specific molecular profile","volume":"35","author":"Momeni-Boroujeni","year":"2022","journal-title":"Mod Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1177\/1933719116648213","article-title":"Discordant mutations in paired primary and metastatic endometrial adenocarcinomas identified by semiconductor-based sequencing for rapid cancer genotyping","volume":"23","author":"Bergstrom","year":"2016","journal-title":"Reprod Sci"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ng.3602","article-title":"The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis","volume":"48","author":"Gibson","year":"2016","journal-title":"Nat Genet"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41388-022-02221-0","article-title":"Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression","volume":"41","author":"Mota","year":"2022","journal-title":"Oncogene"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"e52795","DOI":"10.1371\/journal.pone.0052795","article-title":"High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2, and PIK3CA to be frequently mutated","volume":"7","author":"Krakstad","year":"2012","journal-title":"PLoS One"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"27728","DOI":"10.18632\/oncotarget.25543","article-title":"Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma","volume":"9","author":"Yoshioka","year":"2018","journal-title":"Oncotarget"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-12-3815","article-title":"PI3K pathway dependencies in endometrioid endometrial cancer cell lines","volume":"19","author":"Weigelt","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-017-0600-4","article-title":"Intra-tumor heterogeneity from a cancer stem cell perspective","volume":"16","author":"Prasetyanti","year":"2017","journal-title":"Mol Cancer"},{"key":"R24-20250608","first-page":"5782","article-title":"Cancer stem cells: a major culprit of intra-tumor heterogeneity","volume":"11","author":"Naz","year":"2021","journal-title":"Am J Cancer Res"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1158\/1541-7786.MCR-18-1178","article-title":"Multiclonality and marked branched evolution of low-grade endometrioid endometrial carcinoma","volume":"17","author":"Lazo de la Vega","year":"2019","journal-title":"Mol Cancer Res"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2018.10.032","article-title":"Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression","volume":"152","author":"Ashley","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/PAS.0000000000000663","article-title":"Unusual mismatch repair immunohistochemical patterns in endometrial carcinoma","volume":"40","author":"Watkins","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/PAS.0000000000002031","article-title":"Endometrial carcinomas with subclonal loss of mismatch repair proteins: a clinicopathologic and genomic study","volume":"47","author":"Mendoza","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/modpathol.2016.132","article-title":"Molecular genetic heterogeneity in undifferentiated endometrial carcinomas","volume":"29","author":"Rosa-Rosa","year":"2016","journal-title":"Mod Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pgp.0000183048.22588.18","article-title":"Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?","volume":"25","author":"Silva","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PGP.0000000000000770","article-title":"Dedifferentiation in breast metastasis of endometrial carcinoma: a diagnostic dilemma","volume":"41","author":"Shah","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"108449","DOI":"10.1016\/j.ijscr.2023.108449","article-title":"Dedifferentiated umbilical metastases from low-grade endometrioid endometrial adenocarcinoma complicated by super-obesity: A case report","volume":"108","author":"Odgers","year":"2023","journal-title":"Int J Surg Case Rep"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/his.13091","article-title":"Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM), and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology","volume":"70","author":"Ramalingam","year":"2017","journal-title":"Histopathology"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/PAS.0000000000002088","article-title":"Unusual aspects of small cell carcinoma of the ovary of hypercalcaemic type: retained SMARCA4 immunohistochemical staining and positive staining with TLE1","volume":"47","author":"Mazibrada","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1158\/2159-8290.CD-23-0546","article-title":"Molecular characterization of endometrial carcinomas in black and white patients reveals disparate drivers with therapeutic implications","volume":"13","author":"Weigelt","year":"2023","journal-title":"Cancer Discov"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","volume":"34","author":"da Silva","year":"2021","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:01:39Z","timestamp":1749412899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002308","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}